These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 33217)

  • 21. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
    Yonkosky D; Buffett RF; Bennett M
    J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression by anti-interleukin-2 receptor antibody but not anti-L3T4 requires terminal complement components.
    Kelley VE; Strom TB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):617. PubMed ID: 3274827
    [No Abstract]   [Full Text] [Related]  

  • 24. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST; Radaszkiewicz T; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of polyinosinic:polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment.
    Peres A; Amlani S; Kornbluth M; Seemayer TA; Lapp WS
    Transplantation; 1989 Jul; 48(1):80-4. PubMed ID: 2749889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of active immunological hypo/non-responsiveness to C5 in adult C5-deficient DBA/2 mice.
    van den Berg CW; Hofhuis FM; Rademaker PM; van Dijk H
    Immunology; 1991 Nov; 74(3):380-5. PubMed ID: 1769686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
    Halle-Pannenko O; Pritchard LL; Rappaport H
    Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-induced immune complex disease: genetic control of C1q binding complexes in the circulation of mice persistently infected with lymphocytic choriomeningitis virus.
    Oldstone MB; Tishon A; Buchmeier MJ
    J Immunol; 1983 Feb; 130(2):912-8. PubMed ID: 6217255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
    Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
    Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
    McMaster R; Levy JG
    J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
    Dromer F; Perronne C; Barge J; Vilde JL; Yeni P
    Clin Exp Immunol; 1989 Dec; 78(3):412-7. PubMed ID: 2612053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effects of anti-interleukin 2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope.
    Kelley VE; Gaulton GN; Strom TB
    J Immunol; 1987 May; 138(9):2771-5. PubMed ID: 3106488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of graft versus host reactivity in pregnant mice.
    Nicklin S; Billington WD
    Clin Exp Immunol; 1982 Jul; 49(1):135-41. PubMed ID: 7127896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.